Loading resource…

Sofia Palmieri, PhD; Christopher T. Robertson, JD, PhD; I. Glenn Cohen, JD
The guidance emphasizes the need for multidisciplinary AI governance committees, local validation of AI models, and continuous monitoring for performance issues and bias. It raises critical questions about patient consent and the responsibilities of healthcare organizations in implementing AI technologies. The document also addresses the potential legal implications of noncompliance with these guidelines, highlighting the evolving landscape of AI in medicine and the need for authoritative oversight.
No account needed